Oslo, 26 April 2019

Please find attached the Annual Report for 2018 for Vistin Pharma ASA. There are no material changes in the financial statements compared to the preliminary full year results presented on 19 February 2019, with the exception of the negative income tax expense for the year, which has been reduced by NOK 3.3 million.

The annual report for 2018 will also be made available on www.vistin.com.


For further information, please contact:

Gunnar Manum
+47 95 17 91 90